tirzepatide for ckd kidneys 🧬 New data from the SUMMIT trial reveals that long-term tirzepatide (Zepbound) may Putative mechanisms underlying the renal

Rushing this step leads to dosing errors

Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials

Enough to maintain existing muscle mass for most people

All participants implemented lifestyle changeseating a hypocaloric diet and brisk walking for 20 minutes dailyand were assigned to one of the following treatment groups: tirzepatide therapy (2.5 mg weekly for the first month, increased to 5 mg from the second month

FDA-approved indications require either a BMI of 30+ or BMI of 27+ with comorbidities for weight management, or a type 2 diabetes diagnosis for the diabetes formulations

Take our short quiz